Atlas Trials

Peptide-based Immunization for Colon- and and Pancreas-carcinoma

Clinical trial NCT03871790 · COMPLETED

Trial details

NCT number
NCT03871790
Sponsor
CENTOGENE GmbH Rostock
Status
COMPLETED
Study type
OBSERVATIONAL
Colon NeoplasmColon AdenocarcinomaColon CancerColo-rectal CancerRectal CancerRectal NeoplasmsRectal AdenocarcinomaRectal TumorsPancreatic CancerPancreas CancerPancreatic NeoplasmsPancreatic Adenocarcinoma
Start date
2019-04-01
Primary completion
2022-04-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.